Edwards Lifesciences Report issue

For profit Phase 4
Founded: Santa Ana CA United States (1958)
Status: No NME R&D (1958)

Organization Overview

First Clinical Trial
2012
NCT01559298
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Edwards Lifesciences

Active Ingredients

Drugs in Phase 4 Trials (3)

acetylsalicylic acid (aspirin) (1 trial)

carbetocin (Pabal) (1 trial)

clopidogrel (plavix) (1 trial)

Drugs in Other Trials (1)

Key: Edwards Lifesciences (0) Acquired (1)

lidocaine (xylocaine) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Infarction (Phase 4)

Myocardial Infarction (Phase 4)

Overview

  • Highest Phase: Phase 4
  • # of Trials: 3
  • # of Trial APIs: 4